Amazon Pharmacy offers GLP-1 drugs to Medicare patients at $50/month

Amazon (NASDAQ: AMZN) announced that its pharmacy service will now offer GLP-1 medications, including Wegovy, Zepbound, and Foundayo, to eligible Medicare Part D patients for $50 per month.

Amazon Pharmacy said same-day delivery of GLP-1 medications is currently available in more than 3,100 U.S. cities, with plans to expand to nearly 4,500 cities by the end of 2026.

You May Also Be Interested In

• FTC to file lawsuit alleging Amazon deceived advertisers - WSJ
• New Zealand Energy Corp. swings to profit in Q2 2026
• Knorex to add AI chat interface and MCP server to ad platform